The Innovation Division, through its Business Development (BD) unit, takes steps to promote partnership research, i.e. the conduct of research projects by the Institute's researchers and clinicians in partnership with industrial players (from SMEs to major groups). Partnership research is a major lever for promoting scientific and medical results, accelerating the development and marketing of innovative products for patients. Paris Brain Institute has been awarded the prestigious “Institut Carnot” label, a guarantee of its ability to collaborate effectively and sustainably with industrial partners.
Business development's missions
The BD cluster's mission is to help the Institute's researchers and clinicians choose the most appropriate commercialization strategy and the right industrial partner to ensure that the laboratory's results lead to a concrete results in a concrete solution available to patients. To this end, the BD cluster will on the one hand identify the Institute's valuable assets (know-how, scientific and medical skills, innovative products, tools and software) and create a commercial portfolio; and secondly, prospect for and identify industrial partners with complementary expertise likely to be interested in collaborating with the Institute's researchers and clinicians.
Business development'ambition
The ambition of the BD cluster is to act as a bridge between the Institute and the business world, by making the Institute's unique expertise available to companies in the healthcare field, through a variety of partnerships:
- Collaborations (Cifre theses, co-development, etc.) and services ranging from fundamental
- and pre-clinical research (from the cell to disease mimicking models), to the set-up and management of innovative clinical trials (NeuroTrials)
- Strategic alliances
- Scientific and medical consulting
- Care Lab services based on open innovation and design thinking methodologies Design Thinking methodologies focused on optimizing the patient pathway
- Licensing
